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Abstract: The aim of this study was to investigate the possible antigenotoxic effects of the extract of pomegranate (Punica granatum
L.) peel, which has high antioxidant activity against the genotoxic effects that mitomycin-C creates in the bone marrow cells of mice by
a chromosomal aberration, mitotic activity, and micronucleus test system. There were six groups including a negative control group,
positive control group (2 mg/kg mitomycin-C (MMC)), 150 mg/kg P. granatum L. (PG) peel extract, 300 mg/kg PG peel extract, 150 mg/
kg PG + MMC, and 300 mg/kg PG + MMC. The extract of pomegranate peel was given to mice by oral gavage for 15 days. At the end
of day 15, 2 mg/kg MMC was intraperitoneally administered to the mice. Chromosomal aberration, mitotic activity, and micronucleus
rates were determined in bone marrow cells of the mice, which were euthanized 24 h after this application. As a result of the observations
carried out, it was determined that the chromosomal aberrations and micronucleus ratios in the MMC group were at the maximum
level in terms of chromosomal aberration rates and micronucleated polychromatic erythrocytes; this rate decreased with 150 mg/kg PG
and 300 mg/kg PG peel extract application with MMC, and PG peel extract applied with MMC significantly increased this decrease
due to dose increase (P < 0.001). It was observed that MMC application decreased mitotic activity and polychromatic erythrocyte/
normochromatic erythrocyte ratios, while statistically these rates significantly increased in the groups administered peel extract with
MMC when compared to the MMC group (P < 0.001). As a result, it was determined that the peel extract at the stated dose showed
antigenotoxic effects against the genotoxicity caused by mitomycin-C in the bone marrow cells of mice.
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1. Introduction
Pomegranate (Punica granatum L.) is an important species
of the family Punicaceae used in the treatment of different
diseases in Asia, the Americas, and Africa by general
medicine [1,2]. In recent years, studies on pomegranate have
shown that various chemical components in pomegranate
are important in terms of pharmacological effects. Studies
conducted with separate extracts of pomegranate fruit and
leaf parts have proved its therapeutic properties [3]. The
part of the pomegranate that has the highest antioxidant
capacity is the peel. Pomegranate peel has 10 times more
antioxidant activity when compared to the edible part
and 2 times more when compared to its seeds [4,5].
Studies on pomegranate peel have generally focused on
antioxidant activity and phenolic content. In recent years,
it has been found that pomegranate peel has antidiabetic,
antiviral, anticarcinogenic, and antibacterial properties
[6]. Pomegranate peels, used for wound healing, blood
arresters, diarrhea inhibitors, skin infections, and viral
diseases in the field of traditional medicine, are also used
in the compositions of recommended drugs for various

health disorders such as antimicrobial, antitumoral,
antiinflammatory, and antiulcer drugs, as well as for
diabetes and genital infections, thanks to the studies
carried out in recent years [7–14]. There are important
phenolic compounds such as tannins (punicalagin,
punicalin, elagic acid, and gallic acid) and flavanoids
(catechin, anthocyanin, and other complex flavanoids) in
parts of the pomegranate peel [15,16].
Mitomycin-C (MMC) is a drug isolated from
Streptomyces caespitosus and used for the treatment
of adenocarcinoma and transitional tumors in the
genitourinary system. MMC, an alkylating agent, inhibits
RNA and protein synthesis by breaking the formation of
DNA cross-linking and shows antineoplastic properties
[17–19].
In addition to cross-linking, it is also activated by
quinone reduction followed by C-10 (urethane group) and
at the same time C-7 (aziridine group) in order to exhibit
alkylating properties [20]. During the damage created
by MMC in the DNA as a cross-linking and alkylating
agent, it creates new damage to the DNA by creating free
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radicals. MMC also inhibits the activities of enzymes such
as phagocyte NADPH-oxidase, NADPH-cytochrome
P450, xanthine oxidase, and mitochondrial NADHdehydrogenase. It produces free radicals in electron
reduction reactions with redox cycles that affect most
enzymes and forms a semiquinone midproduct [21,22].
It has been supported by studies that it has significant
therapeutic effects thanks to the presence of compounds
in the pomegranate peel, especially punicalagin and
punicalin. However, no studies have been found on the
possibility of the protective effects of pomegranate peel
extract against genotoxicity caused by MMC. The aim of
this study was to investigate the possible antigenotoxic
effects of pomegranate peel extract on the genotoxicity
created by MMC at determined doses.
2. Materials and methods
2.1. Animals
In the experiments carried out, 48 Mus musculus albino
female mice were used. The mice were each 8 weeks old
and weighed 25 ± 5 g. Animals were obtained from the
Experimental Animals Research and Application Center at
Kafkas University. During the period of the study, the use
of laboratory animals was carried out in accordance with
national ethical rules and was approved by the Animal
Experiments Local Ethics Committee at Kafkas University
(KAÜ-HADYEK: 2017/46).
The mice were provided distilled water and regular
mouse feed ad libitum. Mice, which were checked 3 times
daily, were housed in laboratory conditions with 50%
relative humidity, 20 ± 2 °C temperatures, and a light
period with 12 h of light and 12 h of dark.
2.2. Punica granatum peel extract
Pomegranate (Punica granatum L.) was obtained from the
Antalya region. The peel parts of the fruit were taken and
dried in a sun-free area with air circulation and ground
with an IKA A11 basic laboratory scale mill (Staufen,
Germany). Fifty grams of ground plant sample was
taken into a Soxhlet device cartridge, which was washed
with extraction solvent and then transferred into a 500mL Soxhlet extractor. The solvent was extracted (10-15
siphons) for approximately 10 h until it became clear.
After 10 h, the liquid extracts were filtered using filter
papers with pore size of <2 µm and 110 mm diameter
(Grade 589/3, Whatman, UK) to remove particles. The
filtered extract sample was evaporated with a rotary
evaporator at 35–45 °C. The pomegranate peel extract
remaining in the flask was kept in the desiccator for 12
h. The pomegranate peel extract, which was completely
removed from the solvent, was weighed with sensitivity of
0.1 mg, placed in the extract box, and stored at 4 °C for the
study [23].

2.3. Experimental design
Mice were divided into 6 equal groups after they were fasted
for 24 h (n = 8). Group 1 was the negative control group.
Mice in this group were orally given distilled water for 15
days to allow them to experience the same stress as mice
in the other group. Group 2 contained mice orally given
distilled water for 15 days. The mice were intraperitoneally
given 2 mg/kg mitomycin-C on the 15th day. Group 3
contained mice that were given 150 mg/kg PG peel extract
by oral gavage for 15 days. Group 4 contained mice that
received 300 mg/kg PG peel extract by oral gavage for 15
days. Group 5 contained mice given 150 mg/kg PG peel
extract by oral gavage for 15 days. At the end of the 15th day,
they were intraperitoneally given MMC at a dose of 2 mg/kg.
Group 6 contained mice that were given 300 mg/kg PG peel
extract by oral gavage for 15 days. At the end of the 15th day,
they were intraperitoneally administered MMC at a dose of
2 mg/kg and the experiment was completed. The substances
used in the experiment were administered by preparing the
solution depending on the daily weight results of the mice.
Twenty-four hours after MMC applications, the femoral
bones of the mice were removed by cervical dislocation
under ether anesthesia. Test concentrations (150 mg/kg and
300 mg/kg) were determined considering the lower and
upper limit ranges used in previous studies [24–26].
2.4. Chromosomal examination and detection of mitotic
index
For testing for chromosomal aberration and detection of
the mitotic index, the mice were intraperitoneally given
2 mg/kg colchicine dissolved in distilled water 2 h before
euthanasia. The bone marrow of the femoral bone was
removed with a syringe and taken into centrifuge tubes
containing 3 mL of fetal calf serum. Samples of one of the
femoral bones were centrifuged at 1100 rpm for 10 min to
discard the supernatant. Then 5 mL of 0.075 M KCl solution
was heated for 30 min in an oven set at 37 °C. Cells were
incubated for 20–30 min in warmed hypotonic solution.
After incubation, the cells were centrifuged again at 1100
rpm for 10 min and the supernatant was discarded.
Cells were fixed in 5 mL of cold Carnoy’s solution
(methanol and glacial acetic acid, 3:1) prepared 1 day before
the study. After this step, the supernatant was discarded by
centrifugation again. Then the fixation was repeated 3 times
and the supernatant was discarded, leaving 0.5 mL in the
tube. The cells at the bottom were suspended with a Pasteur
pipette and spread on moist clean slides by dropping them
from 3–4 cm above. After smearing, the preparations were
dried at room temperature for 24 h and stained with 10%
Giemsa dye for 10 min. The preparation of metaphase
preparations for chromosomal aberration and mitotic
activity detection was performed according to Preston et
al. [27]. For chromosomal aberration and the detection
of mitotic activity, mice were intraperitoneally given 2
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mg/kg colchicine dissolved in distilled water 2 h before
euthanasia.
2.5. Micronucleus frequency test
The femur bone marrow was injected into a centrifuge
tube containing 3 mL of fetal calf serum. After the tubes
were centrifuged at 2000 rpm for 5 min, the supernatant
was removed from it and a drop of fetal calf serum was
placed on the part left, and it was suspended. Each drop
of the samples taken from tubes was placed on a moist
and clean slide and smeared. After drying, the prepared
preparations were fixed in methyl alcohol for 10 min. The
fixed preparations were first stained with 0.25% May–
Grünwald dye for 5 min and then washed in distilled
water. In the second stage, they were again stained with
May–Grünwald dye of 0.125% for 5 min and washed
again in distilled water. In the final stage, the preparations
were stained with 20% Giemsa dye for 30 min and then
passed through distilled water again and allowed to dry
(Figure 1). For the detection of micronuclei in mouse bone
marrow preparations, the Schmid method was used as a
reference [28].
2.6. Statistical analysis
IBM SPSS Statistics 22.0 (IBM Corp, Armonk, NY, USA)
was used for statistical assessments. One-way analysis of
variance (ANOVA) was used to compare the differences
between the control and experimental groups. Significant
differences were evaluated at P < 0.05.
3. Results
3.1. Chromosomal aberration rates in the cells of the
bone marrow of control and experimental groups
Six groups including 8 mice in each group were formed to
determine whether pomegranate peel extract, which has

high antioxidant activity due to containing polyphenols,
has any effect on chromosomal aberrations and mitotic
activity by mitomycin-C, which has genotoxic effects in
the bone marrow cells of the female mouse (Mus musculus
var. albinos). Groups were determined as a negative control
group, MMC group, 150 mg/kg PG peel extract group, 300
mg/kg PG peel extract group, 150 mg/kg PG peel extract +
MMC group, and 300 mg/kg PG peel extract + MMC group.
Five preparations were prepared from each of the dose
groups. A total of 100 cells in the metaphase stage were
counted from the preparations obtained from each sample.
The structural chromosomal aberration rates observed in
these 100 cells were determined and are shown in Table 1.
According to the statistical data among the groups,
when chromosomal aberration rates were compared
among the groups in terms of chromosomal aberration
rates, it was observed that the chromosomal aberration rate
in the MMC group was at the maximum level. This ratio
decreased due to the application of 150 mg/kg and 300 mg/
kg PG peel extract together with MMC, and the PG peel
extract applied together with MMC significantly increased
this decrease due to dose increase (P < 0.001) (Figure 2). In
microscopic examination, chromosomal aberration types
such as chromosome fracture (Figure 3), fragment, sister
chromatid association (Figures 4 and 5), and chromatid
fracture (Figure 6) were detected.
3.2. Mitotic activity rates in the bone marrow cells of
control and experimental groups
Five preparations were prepared from each animal. From
the prepared bone marrow preparations, 1000 cells were
randomly counted in each animal. Mitotic activity rates
were determined by counting the cells in the metaphase
stage (Table 2).

Figure 1. Chromosome and micronucleus methods in mouse bone marrow cells.
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Table 1. Chromosomal aberration rates in mouse bone marrow
cells in control and experimental groups.
Chromosomal aberration rates of control and experimental
groups in mouse bone marrow cells
Groups

A

B

C

D

Total

NC

-

1

1

1

3

MMC

30

28

40

36

134

150 mg/kg PG

-

2

1

1

4

150 mg/kg PG + MMC

19

17

20

30

86

300 mg/kg PG

-

3

1

-

4

300 mg/kg PG + MMC

14

10

11

28

63

NC: Negative control group, MMC: mitomycin-C, PG: P.
granatum L., A: chromosome fracture, B: sister chromatid
combination, C: fragments, D: chromatid fracture.

SPSS 22 was used for statistical analysis of the data
obtained from the study. One-way ANOVA was used
to determine the difference between the control and
experimental groups and P < 0.05 was considered
statistically significant.
According to the comparison of the results of mitotic
activity in the groups, MMC application decreased mitotic
activity, whereas it was found that this ratio increased
significantly in the group with PG peel extract together
with MMC compared to the MMC group (P < 0.001)
(Figure 7).
3.3. Micronucleus frequencies of control and
experimental groups in mouse bone marrow cells
Five preparations from each animal were prepared
from bone marrow preparations for micronucleus tests.
Micronucleus frequencies were determined by counting
2000 polychromatic erythrocyte (PCE) cells from just one
animal (Table 3).
When micronucleated polychromatic erythrocyte
(MNPCE) rates were examined, it was observed that

160.00
140.00
120.00
100.00
80.00
60.00
40.00
20.00
0.00

MNPCE rates of animals in the MMC group increased
like the increase in other parameters and this increase
decreased with the application of the PG peel extract, and
this decrease was parallel based on the dose increase of the
PG peel extract (P < 0.001) (Figure 8).
When PCE/normochromatic erythrocyte (NCE)
ratios were examined, it was found that the MMC group
had lower levels compared to the other groups. This ratio
started to increase in the MMC groups treated with PG
peel extract, and this ratio increased in direct proportion
with the dose increase of the PG peel extract and was
statistically significant (P < 0.001) (Figure 9). PCE, NCE,
and MNPCE counts were taken and photographed in
microscopic examination (Figure 10).
4. Discussion
Our study showed that pomegranate extract has protective
effects against MMC-induced genotoxicity. This protective
effect is directly proportional to the dose increase. At the
same time, the data obtained from the groups treated only
with PG peel extract were similar to data from the control
group.
It has been determined in various studies so far that
pomegranate has antioxidant, antiviral, antibacterial,
antidiabetic, anthelmintic, antidiuretic, and antineoplastic
properties. It is also known to prevent tumor metastasis and
show anticarcinogenic effects due to phenolic compounds
found in various parts of pomegranate fruit [29–32].
In order to keep the genotoxic effects of physical and
chemical substances on DNA to a minimum level, the
investigation of antigenotoxic effects of natural herbal
products in recent studies has increased the importance
of natural antioxidants [33]. Humans resist the negative
effects of mutagenic substances they are exposed to thanks
to the natural antioxidants found in their bodies. The
production of natural antioxidants in the body slows down
depending on age. Therefore, people need antioxidant
supplements. Increasing the use of various antigenotoxic
compounds to minimize the effects of DNA damage
caused by genotoxic agents in the living body is known to

Chromosomal aberration
b

d

d

d

NC

150 PG

300 PG

150 PG +
MMC

a

c

300 PG +
MMC

MMC

Figure 2. Chromosomal aberration rates of control and application groups.
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Figure 3. Chromosome fracture image in bone marrow cells of
experimental group mice (A) (1000×).

Figure 5. Sister chromatid association (B) image in bone marrow
cells of experimental group (1000×).

Figure 4. Fragment (C) and sister chromatid association (B)
image in bone marrow cells of experimental group (1000×).

Figure 6. Chromatid fracture (D) image in bone marrow cells of
experimental group (1000×).

be very important in preventing diseases such as cancer
caused by mutations. Various studies have revealed the
presence of compounds with high antioxidant activity
in pomegranate. These useful antioxidants are known as
polyphenols and they are powerful defenders against free
radicals in the body [34–37].
Abdou et al. showed that the PG peel and seed extract
inhibited genotoxic effects induced by CCl4. Chromosomal
aberrations, sperm anomalies, molecular analysis, and
nucleic acid determination were used in that study. The
results documented that CCl4 increases chromosomal
disorders, causes sperm anomalies, and produces
genotoxicity as seen by the number of amplified fragments

of DNA as well as reducing the total soluble protein
content. However, it was observed that the PG significantly
reduced the CCl4 genotoxicity in the groups receiving PG
seed extract. As a result, it is thought that this protective
effect of the PG peel and seed extract with antigenotoxic
effects against CCl4 genotoxicity are thanks to its defensive
ability against antioxidants and free radicals [38].
Hussien et al. investigated the antigenotoxic effects of
PG peel extract against genotoxicity caused by malathion
and atrazine pesticides in a study conducted on male
albino mice. In this study, researchers using the comet
assay analysis method gave the substances they used by oral
gavage for 30 days. The results of this study showed that
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Table 2. Control and experimental groups’ mitotic activity rates in mouse bone marrow cells.

Groups

Number
of subjects

Total cell Number of
count
interphase cells

Number of
metaphase cells

Group average
± SD

Metaphase cell
ratio average (%)

NC

8

8000

7686

314

39.25 ± 1.83a

3.925

MMC

8

8000

7870

130

c

16.25 ± 1.28

1.625

150 mg/kg PG

8

8000

7688

312

39.00 ± 2.00a

3.900

150 mg/kg PG + MMC

8

8000

7831

169

21.12 ± 1.13

2.110

300 mg/kg PG

8

8000

7691

309

a

38.62 ± 2.00

3.862

300 mg/kg PG + MMC

8

8000

7835

165

20.62 ± 1.41b

2.062

b

Different letters in the same column represent statistical significance.

Mitotic activity
45.00
40.00
35.00
30.00
25.00
20.00
15.00
10.00
5.00
0.00

a

NC

a

150 PG

a

300 PG

b

b

150 PG
+
MMC

300 PG
+
MMC

c

MMC

Figure 7. Mitotic activity rates of control and application groups.
Table 3. Micronucleus test results of control and experimental groups

Groups

Total
PCE

MNPCE

MNPCE
(%)

Group average
± SD

Total erythrocytes
(PCE + NCE)

Number
of PCEs

Number
of NCEs

PCE/NCE
ratio

NC

16000

318

1.987

39.75 ± 1.67d

8000

5517

2483

2.21

MMC

16000

757

4.730

a

94.62 ± 1.41

8000

3895

4105

0.94

150 mg/kg PG

16000

329

2.056

41.12 ± 2.42d

8000

5374

2626

2.04

150 mg/kg PG + MMC

16000

565

3.531

b

70.62 ± 1.06

8000

4121

3879

1.05

300 mg/kg PG

16000

331

2.060

41.37 ± 1.69d

8000

5437

2563

2.11

300 mg/kg PG + MMC

16000

482

3.012

60.25 ± 1.49

8000

4731

3269

1.44

c

Different letters in the same column represent statistical significance.

PG peel extract alone showed no significant antigenotoxic
effect against the genotoxicity of malathion and atrazine
pesticides [39].
Malviya et al. investigated the antioxidant and
antibacterial properties of PG peel. The antioxidant
activity of the PG peel extracts made with different solvents
was obtained from ethanolic extract at the highest levels;
on the other hand, the antibacterial activity was tested

against four bacterial strains. They reported that the PG
peel showed antibacterial effects against all tested bacteria
and had significant antioxidant activity in terms of high
phenolic content [40].
Avila et al. investigated the antigenotoxic effects of PG
fruit extract against the genotoxicity caused by chromium
in mouse bone marrow. In this study, carried out for
10 days, doses of the PG fruit extract were given by oral
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PG fruit extract showed significant antigenotoxic effects on
chromium genotoxicity [41].
In an in vivo study on rats, Zahin et al. investigated the
possible antioxidant effects of the punicalagin and ellagic
acid compounds that exist in PG peel by Ames test. In that
study, benzo(a)pyrene (C20H12) was used for mutagenicity.
As a result, it was observed that punicalagin and ellagic
found in PG peel have significant antimutagenic effects
against benzo(a)pyrene-induced mutagenicity in parallel
with the dose [42].
In the studies conducted by Abdou et al. [38], Malviya et
al. [40], Avila et al. [41], and Zahin et al. [42], different parts
of pomegranate plants were extracted with various solvents
using different methods. They reported that all of these
extracts have antigenotoxic, antioxidant, and antibacterial
effects. It is known that the mentioned parameters (such as
method, solvent, part of the plant) play important roles in
the biological effects of plants [43]. In particular, the solvent
plays an important role. Unlike these results, Hussien et al.
directly used pomegranate juice, and they reported that it
was not antigenotoxic. However, in our study, the Soxhlet
method was used for pomegranate extract and only the
peel part of the pomegranate was processed.

Figure 8. MNPCE rates of control and application groups.

gavage at 25, 50, and 75 mg/kg, while chromium was given
intraperitoneally at 30 mg/kg. It was observed that the dose
of the PG fruit extract having the most antigenotoxic effect
was 50 mg/kg. According to the results of the study, the

MNPCE ratios
120.00
100.00
80.00
60.00
40.00
20.00
0.00

a
b
d

d

d

NC

150 PG

300 PG

c

150 PG
+
MMC

300 PG
+
MMC

Figure 9. PCE/NCE ratios of control and application groups.

PCE/NCE ratios
2.50

a

2.00

c

b
d

1.50

e

1.00

f

0.50
0.00

NC

150 PG

300 PG

150 PG
+
MMC

300 PG
+
MMC

MMC

Figure 10. Microscopic image of PCE, NCE, and MNPCEs in
bone marrow cells of experimental group (1000×).
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According to chromosomal aberration, mitotic activity,
and micronucleus analysis results of the present study, the
determined doses of the PG peel extracts did not show
any genotoxic effects. It was observed that the parameters
examined for PG peel extracts were very close to those
of the control group. Assessing chromosomal aberration
rates, it was found that aberration rates were highest in the
MMC group and 150 mg/kg and 300 mg/kg of PG peel
extracts together with MMC decreased these levels based
on dose increase (P < 0.001).
In terms of the mitotic activity rates, the mitotic activity
level was low in the MMC group, while it was found that
in the groups with PG peel extract together with MMC,
the mitotic activity rate significantly increased compared
to the MMC group (P < 0.001).
According to the results of the micronucleus analysis,
PCE/NCE ratios were observed at low levels in the MMC
group, while these ratios increased in the groups with PG
peel extract and were directly proportional to the dose

increase. In addition, this was found to be significant in
terms of statistical results (P < 0.001).
When MNPCE ratios were examined, it was observed
that they showed high values similar to other parameters
in the groups with MMC, and the inhibitory effect of PG
peel extract showed inhibitory effects on these high values
based on the dose (P < 0.001).
In conclusion, it has been revealed by many studies that
P. granatum is rich in phenolic compounds. It can be said
that P. granatum peel extract used in the dosages indicated
in this study showed antimutagenic-antigenotoxic effects as
a result of micronucleus, mitotic index, and chromosomal
aberration tests.
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